Anaergia (ANRG) Q2 2024 earnings summary

Executive summary

• Q2 2024 marked continued transition to a capital-light business model, resulting in improved gross profit margins and adjusted EBITDA despite a significant revenue decline year-over-year.

• Focus remains on margin improvement, expense reduction, and cash conservation, leveraging proprietary technologies for sales growth.

Financial highlights

• Revenue for Q2 2024 was $23.6 million, down 45% from Q2 2023, mainly due to completed Italian Capital Sales projects and project delays.

• Gross profit margin rose to 17.6% in Q2 2024 from 9.0% in Q2 2023, a 96% increase, driven by higher-margin contracts.

• Net loss improved by 89% to $13.4 million, compared to a $117.5 million loss in Q2 2023, reflecting the absence of prior year non-recurring losses.

• Adjusted EBITDA loss improved by 59% to negative $8.0 million, supported by operational improvements and lower SG&A expenses.

• For the six months ended June 30, 2024, revenue was $48.6 million (down 39%), gross profit $10.6 million (up 19%), and net loss $24.8 million (improved by 80%).

Outlook and guidance

• Management continues to prioritize margin expansion, cost control, and cash preservation as the business model shifts.

• Forward-looking statements highlight ongoing risks and uncertainties, with no assurance of future performance.